Search - tctmd.com

Displaying 241 - 260 of 410

Sort: Relevancy | Date

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

September 20, 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

September 19, 2019

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

News Opinion Off Script

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Mamas Mamas, BMBCh

August 23, 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

August 22, 2019

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Industry News

Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism

July 29, 2019

TCTMD’s Top 10 Most Popular Stories for June 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

June 28, 2019

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

June 24, 2019

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

June 20, 2019

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

June 19, 2019

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

June 17, 2019

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

June 10, 2019

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

News Daily News

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

June 03, 2019

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

News Daily News

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

May 30, 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

May 16, 2019

News Industry News

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

May 07, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.